| Akt | Protein kinase B |
| APC | Activated protein C |
| APC-PCI | Plasma concentrations of activated protein C-inhibitor of protein C |
| APE | Acute pulmonary embolism |
| ATP | Adenosine triphosphate |
| Bcl-2 | B-cell lymphoma 2 |
| CAD | Coronary artery disease |
| CCL | Chemokine C-C motif ligand |
| CTEPH | Chronic thromboembolic pulmonary hypertension |
| CXCL12 | Chemokine C-X-C motif ligand 12 |
| Del/Ins | Deletion-insertion |
| DVT | Venous thrombosis that includes both deep vein thrombosis |
| EC | Endothelial cells |
| EPC | Endothelial progenitor cells |
| ET-1 | Endothelin-1 |
| F11 | Coagulation factor FXI |
| F2 | Coagulation factor II gene |
| F7 | Coagulation factor VII gene |
| F8 | Coagulation factor VIII gene |
| F9 | Coagulation factor IX gene |
| FasL | Fas ligant (FasL or CD95L or CD178) is a type-II transmembrane protein that belongs to the tumor necrosis factor (TNF) family |
| FASL | Gene encoded Fas ligand |
| FGA | Fibrinogen alpha gene |
| FGB | Fibrinogen beta gene |
| FGG | Fibrinogen gamma gene |
| FI | Coagulation factor I, fibrinogen |
| FII | Prothrombin, coagulation factor II |
| FIX | Coagulation factor IX |
| FVII | Coagulation factor VII |
| FVIII | Coagulation factor VIII |
| FX | Coagulation factor X |
| FXI | Coagulation factor XI |
| GABA | Gamma-aminobutyric acid receptors |
| GABARAPL1 | GABA Type A receptor associated protein like 1 |
| HA | Hemophilia A, coagulation FVIII deficiency |
| HB | Hemophilia B, coagulation FIX deficiency |
| HC | Hemophilia C, coagulation FXI deficiency |
| HepG2 | Liver hepatocellular cells |
| Huh-7 | Human liver cell line |
| HUVEC | Human umbilical vein endothelial cells |
| ICAM-1 | Intercellular adhesion molecule 1 |
| IL-6 | Interleukin-6 |
| IL-8 | Interleukin-8 |
| KLKB1 | gene encoded plasma kallikrein |
| LDL | Low-density lipoprotein |
| MAPK | Mitogen-activated protein kinase |
| MCF7 | Breast cancer cell line acronym of Michigan Cancer Foundation-7 |
| miRNA | MicroRNAs |
| MMP2 | Proteins of the matrix metalloproteinase |
| mRNA | Messenger RNA |
| NF-κB | Nuclear factor-κB |
| NMD | Nonsense-mediated mRNA decay |
| OS | Osteosarcoma |
| PBMC | Peripheral blood mononuclear cells |
| PE | Pulmonary embolism |
| PI3K | Phosphoinositide 3-kinases |
| PIK3R2 | Phosphoinositide-3-kinase regulatory subunit 2 which affected PI3K/Akt |
| PLG | Plasminogen, fibrinolytic protease |
| PROS | Protein S gene |
| PROZ | protein Z, vitamin K dependent plasma glycoprotein gene |
| PS | Protein S |
| PTC | Premature termination codon |
| PTEN | Phosphatase and tensin homolog |
| PTS | Post-thrombotic syndrome |
| SERPINA | Serpin family A member 1 gene |
| SERPINC1 | Serpin family C member 1 gene |
| SERPIND1 | SERPIND1 gene encoded heparin cofactor II (HCII) |
| SRC | Proto-oncogene tyrosine-protein kinase Src |
| SRCIN1 | SRC kinase signaling inhibitor 1 |
| SRF | Serum response factor |
| TGFBR1 | Transforming growth factor beta receptor 1 |
| TF | Tissue factor, coagulation factor III |
| TFPI | Tissue factor pathway inhibitor |
| TIC | Trauma-induced coagulopathy patients |
| TNF-α | Tumor necrosis factor alpha |
| UTR | Untranslated regions |
| VCAM-1 | Vascular cell adhesion molecule-1 |
| VWF | Von Willebrand factor |
| VWD | Von Willebrand disease |